PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))

Term ID

CHEBI:88642

Synonyms

1-(9Z-Octadecenoyl)-2-(8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
1-Oleoyl-2-eicsoate
1-Oleoyl-2-eicsoatetraenoyl-sn-glycero-3-phosphoinositol
1-Oleoyl-2-eicsoic acid
[(2R)-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy]({[(1s,3R)-2,3,4,5,6-pentahydroxycyclohexyl]oxy})phosphinic acid
Phosphatidylinositol(18:1/20:4)
Phosphatidylinositol(18:1n9/20:4n3)
Phosphatidylinositol(18:1w9/20:4w3)
Phosphatidylinositol(38:5)
PI(18:1/20:4)
PI(18:1n9/20:4n3)
PI(18:1w9/20:4w3)
PI(38:5)
PIno(18:1/20:4)
PIno(18:1n9/20:4n3)
PIno(18:1w9/20:4w3)
PIno(38:5)

(all 17)

Definition

References

(all 4)

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype where environments contain PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype modified by environments containing PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))

Phenotype affecting PI(18:1(9Z)/20:4(8Z,11Z,14Z,17Z))

Human Disease Model